Nicox: Presentation at the World Glaucoma Congress of Data on NCX 470 from the Adaptive Dose Selection Step of the Phase 3 Mont Blanc Study and Analysis of Patient Subgroups Showing Superiority of NCX 470 compared to latanoprost – 07/03/2023 at 07:41

Nicox announced that additional data on NCX 470 was presented at the 10th World Glaucoma Congress (WGC) held from June 28 to July 1, 2023 in Rome, Italy. NCX 470 is a new nitric oxide (NO)-donating bimatoprost eye drops in phase 3 clinical development for the reduction of intraocular pressure (IOP) in patients with open-angle…

Read More

Criticism of the Federal Council’s plan – electronic patient dossier in a headwind – News

Contents Author: Philip Schrämmli In the future, everyone in Switzerland should receive an electronic patient dossier free of charge. All healthcare providers will be required to keep such dossiers. The Federal Council presented a corresponding revision of the law on Wednesday. Although there are already electronic patient dossiers in this country, they have hardly been…

Read More